RESUMEN
Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by proto-oncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.
Asunto(s)
Receptor EphB2/metabolismo , Transducción de Señal , Animales , Movimiento Celular , Proliferación Celular , Ciclina D1/metabolismo , Epitelio , Humanos , Intestino Delgado/citología , Intestino Delgado/metabolismo , Masculino , Ratones , Células Madre/citologíaRESUMEN
Alzheimer's and other neurodegenerative diseases are chronic conditions affecting millions of individuals worldwide. Oxidative stress is a consistent component described in the development of many neurodegenerative diseases. Therefore, innovative strategies to develop drug candidates that overcome oxidative stress in the brain are needed. To target these challenges, a new, water-soluble 12-membered tetraaza macrocyclic pyridinophane L4 was designed and produced using a building-block approach. Potentiometric data show that the neutral species of L4 provides interesting zwitterionic behavior at physiological pH, akin to amino acids, and a nearly ideal isoelectric point of 7.3. The copper(II) complex of L4 was evaluated by X-ray diffraction and cyclic voltammetry to show the potential modes of antioxidant activity derived, which was also demonstrated by 2,2-diphenyl-1-picrylhydrazyl and coumarin carboxylic acid antioxidant assays. L4 was shown to have dramatically enhanced antioxidant activity and increased biological compatibility compared to parent molecules reported previously. L4 attenuated hydrogen peroxide (H2O2)-induced cell viability loss more efficiently than precursor molecules in the mouse hippocampal HT-22 cell model. L4 also showed potent (fM) level protection against H2O2 cell death in a BV2 microglial cell culture. Western blot studies indicated that L4 enhanced the cellular antioxidant defense capacity via Nrf2 signaling activation as well. Moreover, a low-cost analysis and high metabolic stability in phase I and II models were observed. These encouraging results show how the rational design of lead compounds is a suitable strategy for the development of treatments for neurodegenerative diseases where oxidative stress plays a substantial role.
RESUMEN
Alzheimer's disease (AD) is characterized, in part, by atrophy of the adult brain and increased presence of extracellular amyloid-beta (Aß) plaques. Previous studies in our lab have shown that peripheral inflammation can lead to increased central Aß and deficits in learning and memory. In order to determine whether Aß accumulation in the brain is responsible for the learning deficits, we attempted to decrease peripheral production of Aß in order to reduce central Aß accumulation. It has previously been shown that Aß is produced in large quantities in the liver, and is transferred across the blood-brain barrier (BBB). Recent research has shown that peripheral treatment with imatinib methanesulfonate salt (IM), known to interfere with the interaction between gamma (γ)-secretase and the γ-secretase activating protein (GSAP), decreases the cleavage of peripheral amyloid precursor protein into Aß. Because IM poorly penetrates the BBB, we hypothesized that co-administration of IM with LPS would decrease peripheral production of Aß in the presence of LPS-induced inflammation, leading to a decrease in Aß accumulation in the hippocampus. We show that peripheral IM treatment eliminates hippocampal Aß elevation that follows LPS-induced peripheral inflammation. Importantly, IM also eliminates the cognitive impairment seen following seven consecutive days of LPS administration, implicating Aß peptides as a likely cause of these cognitive deficits.
Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Benzamidas/administración & dosificación , Trastornos del Conocimiento/prevención & control , Endotoxinas/toxicidad , Hipocampo/metabolismo , Fragmentos de Péptidos/antagonistas & inhibidores , Piperazinas/administración & dosificación , Pirimidinas/administración & dosificación , Secretasas de la Proteína Precursora del Amiloide/antagonistas & inhibidores , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Péptidos beta-Amiloides/metabolismo , Animales , Trastornos del Conocimiento/inmunología , Trastornos del Conocimiento/fisiopatología , Modelos Animales de Enfermedad , Regulación hacia Abajo/inmunología , Hipocampo/efectos de los fármacos , Humanos , Mesilato de Imatinib , Lipopolisacáridos/antagonistas & inhibidores , Masculino , Ratones , Ratones Endogámicos C57BL , Fragmentos de Péptidos/metabolismoRESUMEN
The effects of synthetic, free-amino acid diets, similar to those prescribed as supplements for (phenylketonuria) PKU patients, on gut microbiota and overall health are not well understood. In the current, multidisciplinary study, we examined the effects of a synthetically-derived, low-fiber, amino acid diet on behavior, cognition, gut microbiome composition, and inflammatory markers. A cohort of 20 male C57BL/6J mice were randomly assigned to either a standard or synthetic diet (n = 10) at post-natal day 21 and maintained for 13 weeks. Sequencing of the 16S rRNA gene from fecal samples revealed decreased bacterial diversity, increased abundance of bacteria associated with disease, such as Prevotella, and a downward shift in gut microbiota associated with fermentation pathways in the synthetic diet group. Furthermore, there were decreased levels of short chain fatty acids and shortening of the colon in mice consuming the synthetic diet. Finally, we measured TNF-α, IL-6, and IL-10 in serum, the hippocampus, and colon, and found that the synthetic diet significantly increased IL-6 production in the hippocampus. These results demonstrate the importance of a multidisciplinary approach to future diet and microbiome studies, as diet not only impacts the gut microbiome composition but potentially systemic health as well.
RESUMEN
Peripherally administered inflammatory stimuli, such as lipopolysaccharide (LPS), induce the synthesis and release of proinflammatory cytokines and chemokines in the periphery and the central nervous system, and trigger a variety of neurobiological responses. Indeed, prior reports indicate that peripheral LPS administration in rats disrupts contextual fear memory consolidation processes, potentially due to elevated cytokine expression. We used a similar, but partially olfaction-based, contextual fear conditioning paradigm to examine the effects of LPS on memory consolidation and reconsolidation in mice. Additionally, interleukin-1ß (IL-1ß), brain-derived neurotrophic factor (BDNF), and zinc finger (Zif)-268 mRNA expression in the hippocampus and the cortex, along with peripheral cytokines and chemokines, were assessed. As hypothesized, LPS administered immediately or 2 h, but not 12 h, post-training impaired memory consolidation processes that support the storage of the conditioned contextual fear memory. Additionally, as hypothesized, LPS administered immediately following the fear memory trace reactivation session impaired memory reconsolidation processes. Four hours post-injection, both central cytokine and peripheral cytokine and chemokine levels were heightened in LPS-treated animals, with a simultaneous decrease in BDNF, but not Zif-268, mRNA. Collectively, these data reinforce prior work showing LPS- and cytokine-related effects on memory consolidation, and extend this work to memory reconsolidation.
Asunto(s)
Endotoxinas/farmacología , Lipopolisacáridos/farmacología , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/psicología , Animales , Conducta Animal/efectos de los fármacos , Química Encefálica/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Quimiocinas/biosíntesis , Condicionamiento Operante/efectos de los fármacos , Citocinas/biosíntesis , Discriminación en Psicología/efectos de los fármacos , Proteína 1 de la Respuesta de Crecimiento Precoz/biosíntesis , Miedo/psicología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Interleucina-1beta/biosíntesis , Aprendizaje/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Reacción en Cadena en Tiempo Real de la Polimerasa , Pérdida de Peso/efectos de los fármacosRESUMEN
Currently, over 44 million people worldwide suffer from Alzheimer's disease (AD). A common feature of AD is disrupted sleep. Sleep is essential for many psychological and physiological functions, though 35.3% of adults report getting less than 7 hours per night. The present research examined whether chronic sleep restriction would elevate hippocampal amyloid-beta1-42 expression or alter cognitive ability in adult C57BL/6 mice. Chronic sleep restriction was associated with cognitive impairment and increased hippocampal amyloid-beta. Thus, chronic sleep loss may have a detrimental effect upon cognitive function, in part, via increasing amyloid-beta levels in the hippocampus, even in non-genetically modified mice.
Asunto(s)
Enfermedad de Alzheimer , Péptidos beta-Amiloides , Cognición , Hipocampo , Privación de Sueño , Péptidos beta-Amiloides/metabolismo , Animales , Modelos Animales de Enfermedad , Hipocampo/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , SueñoRESUMEN
Two important new reports identify endocytosis of EphB-ephrinB complexes as a mechanism for switching between cell-cell adhesion and repulsion following plasma membrane contact. Together with the previously described shedding of ephrinA following EphA engagement, these findings resolve the paradox of how an adhesive receptor-ligand interaction generates a repulsive cellular response.
Asunto(s)
Endocitosis/fisiología , Efrina-B1/fisiología , Receptores de la Familia Eph/fisiología , Animales , Adhesión Celular/fisiología , Membrana Celular/fisiología , Movimiento Celular/fisiologíaRESUMEN
The adult brain maintains two regions of neurogenesis from which new neurons are born, migrate to their appropriate location, and become incorporated into the circuitry of the CNS. One of these, the subgranular zone of the hippocampal dentate gyrus, is of primary interest because of the role of this region in learning and memory. We show that mice lacking EphB1, and more profoundly EphB1 and EphB2, have significantly fewer neural progenitors in the hippocampus. Furthermore, other aspects of neurogenesis, such as polarity, cell positioning, and proliferation are disrupted in animals lacking the EphB1 receptor or its cognate ephrin-B3 ligand. Our data strongly suggest that EphB1 and ephrin-B3 cooperatively regulate the proliferation and migration of neural progenitors in the hippocampus and should be added to a short list of candidate target molecules for modulating the production and integration of new neurons as a treatment for neurodegenerative diseases or brain injury.
Asunto(s)
Movimiento Celular/fisiología , Polaridad Celular/fisiología , Proliferación Celular , Hipocampo/citología , Neuronas/citología , Receptores de la Familia Eph/fisiología , Células Madre/fisiología , Animales , Hipocampo/metabolismo , Hipocampo/fisiología , Ratones , Ratones Transgénicos , Neuronas/fisiología , Receptor EphB1/biosíntesis , Receptor EphB1/genética , Receptor EphB1/fisiología , Receptor EphB3/biosíntesis , Receptor EphB3/genética , Receptor EphB3/fisiología , Receptores de la Familia Eph/biosíntesis , Receptores de la Familia Eph/genética , Células Madre/citología , Células Madre/metabolismoRESUMEN
The interactions between Eph receptor tyrosine kinases and their ephrin ligands regulate cell migration and axon pathfinding. The EphA receptors are generally thought to become activated by ephrin-A ligands, whereas the EphB receptors interact with ephrin-B ligands. Here we show that two of the most widely studied of these molecules, EphB2 and ephrin-A5, which have never been described to interact with each other, do in fact bind one another with high affinity. Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling. Ephrin-A5 induces EphB2-mediated growth cone collapse and neurite retraction in a model system. We further show, using X-ray crystallography, that the ephrin-A5-EphB2 complex is a heterodimer and is architecturally distinct from the tetrameric EphB2-ephrin-B2 structure. The structural data reveal the molecular basis for EphB2-ephrin-A5 signaling and provide a framework for understanding the complexities of functional interactions and crosstalk between A- and B-subclass Eph receptors and ephrins.
Asunto(s)
Efrina-A5/metabolismo , Efrina-B2/metabolismo , Receptor EphB2/metabolismo , Transducción de Señal/fisiología , Fosfatasa Alcalina/metabolismo , Animales , Animales Recién Nacidos , Línea Celular , Cromatografía en Gel/métodos , Cromatografía por Intercambio Iónico/métodos , Cricetinae , Cricetulus , Cristalografía/métodos , Electroforesis/métodos , Efrina-A5/química , Técnica del Anticuerpo Fluorescente/métodos , Proteínas Fluorescentes Verdes , Humanos , Infecciones , Proteínas Luminiscentes/metabolismo , Ratones , Neuritas/fisiología , Neuroblastoma , Fosforilación , Unión Proteica/fisiología , Receptor EphA3/metabolismo , Receptor EphB2/química , Virus Sindbis , Espectrometría de Fluorescencia/métodos , Resonancia por Plasmón de Superficie/métodos , Factores de Tiempo , Transfección/métodos , Grabación en VideoRESUMEN
The ability to transport cations and anions across epithelia is critical for the regulation of pH, ionic homeostasis, and volume of extracellular fluids. Although the transporters and channels that facilitate ion and water movement across cell membranes are well known, the molecular mechanisms and signal transduction events that regulate these activities remain poorly understood. The Eph family of receptor tyrosine kinases and their membrane-anchored ephrin ligands are well known to transduce bidirectional signals that control axon guidance and other cell migration/adhesion events during development. However, these molecules are also expressed in non-motile epithelial cells, including EphB2 in K(+)-secreting vestibular dark cells and ephrin-B2 in the adjacent transitional cells of the inner ear. Consistent with these expression patterns, mice with cytoplasmic domain mutations that interfere with EphB2 forward signaling or ephrin-B2 reverse signaling exhibit a hyperactive circling (waltzing) locomotion associated with a decreased amount of endolymph fluid that normally fills the vestibular labyrinth. Endolymph is unusual as an extracellular fluid in that it is normally high in K(+) and low in Na(+). Direct measurement of this fluid in live animals revealed significant decreases in K(+) concentration and endolymphatic potential in both EphB2 and ephrin-B2 mutant mice. Our findings provide evidence that bidirectional signaling mediated by B-subclass Ephs and ephrins controls the production and ionic homeostasis of endolymph fluid and thereby provide the first evidence that these molecules can control the activities of mature epithelial cells.
Asunto(s)
Endolinfa/fisiología , Efrina-B2/fisiología , Receptor EphB2/fisiología , Animales , Efrina-B2/deficiencia , Efrina-B2/genética , Femenino , Heterocigoto , Homeostasis , Concentración de Iones de Hidrógeno , Inmunohistoquímica , Masculino , Ratones , Ratones Noqueados , Ratones Mutantes , Mutación , Potasio/metabolismo , Embarazo , Receptor EphB2/genética , Transducción de Señal , Sodio/metabolismo , Vestíbulo del Laberinto/patología , Vestíbulo del Laberinto/fisiologíaRESUMEN
Alzheimer's disease (AD) is a progressive disorder characterized by neuronal and behavioral deterioration. Two hallmark pathologies of AD are amyloid-beta (Aß) plaques and neurofibrillary tangles, and the presence of such pathology can limit cell-to-cell communication, leading to cognitive deficits, and neuronal cell death. Although Aß plaques were originally thought to cause the cognitive deficits, more simple forms of Aß, such as monomers, dimers, tetramers and oligomers, have also been shown to be neurotoxic. Moreover, chronic inflammation has also been implicated in the onset and progression of these AD-related pathologies. The current study was designed to further our understanding of peripheral inflammation-induced AD-like pathology, by administering polyinosinic:polycytidylic acid (poly I:C), a viral mimetic. Mice were administered intraperitoneal injections of poly I:C or saline once daily for 7 consecutive days. Hippocampal tissue from animals receiving poly I:C contained significantly higher levels of the Aß1â42 peptide. Even after ensuring that potential sickness behavior could not confound cognitive testing, we found that animals administered poly I:C displayed significant cognitive deficits in the hippocampus-dependent contextual fear conditioning paradigm. These results confirm our hypothesis that peripheral inflammation can lead to increased levels of hippocampal-Aß and associated cognitive deficits.
Asunto(s)
Péptidos beta-Amiloides/metabolismo , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/patología , Inductores de Interferón/toxicidad , Fragmentos de Péptidos/metabolismo , Poli I-C/toxicidad , Análisis de Varianza , Animales , Citocinas/metabolismo , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Reacción Cataléptica de Congelación/efectos de los fármacos , Hipocampo/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Factores de TiempoRESUMEN
In the current study, the partial NMDA receptor agonist D-cycloserine (DCS) rescued memory consolidation following systemic bacterial endotoxin exposure. DCS failed, however, to restore hippocampal BDNF mRNA levels that were diminished following a systemic administration of LPS, and did not alter NR1 or NR2C NMDA receptor subunit expression. These results extend prior research into the role of DCS in neural-immune interactions, and indicate that the detrimental effects of peripheral LPS administration on consolidation of contextual fear memory may be ameliorated with DCS treatment, though the mechanisms underlying these effects are currently unclear.
Asunto(s)
Cicloserina/uso terapéutico , Escherichia coli , Hipocampo/efectos de los fármacos , Lipopolisacáridos/farmacología , Memoria/efectos de los fármacos , Animales , Antimetabolitos/farmacología , Antimetabolitos/uso terapéutico , Conducta Animal/efectos de los fármacos , Cicloserina/farmacología , Escherichia coli/efectos de los fármacos , Miedo/efectos de los fármacos , Hipocampo/metabolismo , Hipocampo/microbiología , Lipopolisacáridos/administración & dosificación , Masculino , Ratones , Ratones Endogámicos C57BL , Pruebas Neuropsicológicas , ARN Mensajero/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/biosíntesisRESUMEN
Poly I:C, a viral mimetic, is a synthetic double-stranded RNA that is known to cause activation of the innate immune system, resulting in the emergence of sickness behaviors in otherwise healthy adult mice. However, the way in which such effects of poly I:C manifest themselves in aged mice are not currently known. We hypothesized that poly I:C administration would lead to burrowing deficits, but that these deficits would be exaggerated in aged subjects (19-months old) compared to young subjects (4-months old) that received the same dose. In order to associate these behavioral decrements with inflammatory factors, we measured mRNA expression of IL-1ß and IL-6 in the hippocampus and parietal cortex and peripheral protein expression of IL-6, TNF-α, MCP-1, MIP-1α, and IL-1ß in the serum. After exposure to poly I:C, aged subjects demonstrated significant impairments in their burrowing behavior, compared to younger subjects administered the same dose. These behavioral decrements coincided with increased expression of IL-6 among animals exposed to poly I:C and increased expression of IL-1ß among aged animals in the hippocampus and cortex. Furthermore, we observed an increase in peripheral poly I:C-induced IL-6, TNF-α, MCP-1, and MIP-1α, but not IL-1ß. These results indicate that virus-mediated immune activation in the aging body can lead to increased sickness behavior. Furthermore, these data indicated a possible dissociation between the effects of poly I:C on sickness behaviors in aged mice, with central expression of IL-1ß potentially playing a role in age-related impairments.
Asunto(s)
Envejecimiento/inmunología , Citocinas/metabolismo , Conducta de Enfermedad/fisiología , Poli I-C/inmunología , Envejecimiento/fisiología , Animales , Conducta Animal/fisiología , Materiales Biomiméticos , Quimiocinas/metabolismo , Hipocampo/inmunología , Hipocampo/metabolismo , Interleucinas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Lóbulo Parietal/inmunología , Lóbulo Parietal/metabolismoRESUMEN
In the current study, administration of poly I:C induced a deficit in contextual, but not auditory-cue, fear memory consolidation. This memory deficit coincided with a decrease in hippocampal and cortical BDNF mRNA expression. These results extend prior work, and suggest that a single peripheral injection of poly I:C disrupts contextual fear memory consolidation processes in adult mice, and that these deficits may potentially be mediated by diminished BDNF expression.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/metabolismo , Condicionamiento Psicológico/efectos de los fármacos , Miedo/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Poli I-C/efectos adversos , Análisis de Varianza , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Citocinas/metabolismo , Reacción Cataléptica de Congelación/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/metabolismo , Factores de TiempoRESUMEN
Alzheimer's disease (AD) is characterized by neuronal cell death and atrophy in regions of the adult brain, including the hippocampus and cortex, due to formation of amyloid beta (Aß) plaques and neurofibrillary tangles. The presence of these pathologies can limit normal signaling properties and ultimately lead to learning and memory deficits. Chronic inflammation has been implicated in the onset and progression of these AD-related pathologies. Our study was designed to assess the effects of peripheral inflammation on pathologies associated with AD by using the bacterial endotoxin lipopolysaccharide (LPS). C57BL/6J mice were given intraperitoneal injections of LPS or saline for 1, 3, or 7 consecutive days. Hippocampal tissue from animals receiving LPS contained significantly higher levels of Aß1-42, a peptide component of AD plaques, than did those from saline control animals. Central and peripheral pro-inflammatory cytokine levels were increased following a single injection of LPS, but retuned to baseline levels before cognitive testing began. We show that one injection of LPS leads to sickness behavior, but 7 consecutive days does not, indicating tolerance to the endotoxin. Cognitive testing was then conducted to determine if whether deficits from increased Aß1-42 was evident. Results from both Morris water maze and contextual fear conditioning revealed cognitive deficits in LPS-treated mice. In summary, multiple injections of LPS resulted in increased Aß1-42 in the hippocampus and cognitive deficits in mice.
Asunto(s)
Péptidos beta-Amiloides/metabolismo , Trastornos del Conocimiento/inducido químicamente , Endotoxinas/efectos adversos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Lipopolisacáridos/efectos adversos , Fragmentos de Péptidos/metabolismo , Análisis de Varianza , Animales , Trastornos del Conocimiento/sangre , Condicionamiento Psicológico/efectos de los fármacos , Esquema de Medicación , Ensayo de Inmunoadsorción Enzimática , Conducta Exploratoria/efectos de los fármacos , Miedo/efectos de los fármacos , Inflamación/inducido químicamente , Inflamación/complicaciones , Inflamación/metabolismo , Inflamación/patología , Interleucina-1beta/sangre , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Factores de Tiempo , Pérdida de Peso/efectos de los fármacosRESUMEN
In the current study, we extend our own previous results on the thymocyte phenotype of EphB2 and/or EphB3 deficient mice by analyzing the phenotype and the histological organization of their thymic epithelial stroma. All studied adult EphB-deficient thymi showed profound alterations with respect to the wild-type (WT) ones. Each mutant exhibited a specific phenotype, but also showed common features including occurrence of K5+K8+MTS10+ immature medullary epithelial cells, numerous K5-K8-MTS20+ cells and K5+K8+ cells in the thymic cortex and cortical and medullary K5-K8- areas devoid of epithelial cell markers. In addition, comparative analysis of WT and EphB-deficient embryonic and newborn thymi demonstrated that the observed adult phenotype was a consequence of the gradual accumulation of early phenotypic and morphological defects, becoming more severe at the end of embryonic life and in newborn animals. Together, these results confirm a role for EphB2 and EphB3 in thymus morphogenesis. The obtained data are discussed from the point of view of the recognized role played by these two Ephs in the homeostasis of other epithelia and their possible relationships with molecules known to be involved in thymic epithelial cell development.
Asunto(s)
Receptor EphB2/fisiología , Receptor EphB3/fisiología , Timo/embriología , Timo/crecimiento & desarrollo , Animales , Animales Recién Nacidos , Epitelio/anomalías , Epitelio/embriología , Epitelio/crecimiento & desarrollo , Epitelio/fisiología , Femenino , Antígenos de Histocompatibilidad Clase II/metabolismo , Queratina-15 , Queratina-5/metabolismo , Queratina-8/metabolismo , Laminina/metabolismo , Ratones , Ratones Noqueados , Morfogénesis/genética , Morfogénesis/fisiología , Fenotipo , Embarazo , Receptor EphB2/deficiencia , Receptor EphB2/genética , Receptor EphB3/deficiencia , Receptor EphB3/genética , Transducción de Señal , Timo/anomalías , Timo/fisiologíaRESUMEN
More than 10(10) cells are generated every day in the human intestine. Wnt proteins are key regulators of proliferation and are known endogenous mitogens for intestinal progenitor cells. The positioning of cells within the stem cell niche in the intestinal epithelium is controlled by B subclass ephrins through their interaction with EphB receptors. We report that EphB receptors, in addition to directing cell migration, regulate proliferation in the intestine. EphB signaling promotes cell-cycle reentry of progenitor cells and accounts for approximately 50% of the mitogenic activity in the adult mouse small intestine and colon. These data establish EphB receptors as key coordinators of migration and proliferation in the intestinal stem cell niche.
Asunto(s)
Movimiento Celular , Proliferación Celular , Intestinos/citología , Receptor EphB2/fisiología , Receptor EphB3/fisiología , Células Madre/citología , Adenoma/metabolismo , Adenoma/patología , Animales , Ciclo Celular , Diferenciación Celular , Colon/citología , Colon/metabolismo , Humanos , Técnicas In Vitro , Mucosa Intestinal/metabolismo , Neoplasias Intestinales/metabolismo , Neoplasias Intestinales/patología , Intestino Delgado/citología , Intestino Delgado/metabolismo , Ratones , Ratones Noqueados , Receptor EphB2/biosíntesis , Receptor EphB2/genética , Receptor EphB3/biosíntesis , Receptor EphB3/genética , Transducción de Señal , Proteínas Wnt/fisiologíaRESUMEN
To identify novel molecular mechanisms by which ceramide regulates cell differentiation, we examined its effect on adipogenesis of 3T3-L1 preadipocytes. Hormonal stimulation of 3T3-L1 preadipocytes induced formation of triacylglycerol-laden adipocytes over 7 days; in part, via the co-ordinated action of CCAAT-enhancer-binding proteins alpha, beta and delta (C/EBP-alpha, -beta and -delta) and peroxisome-proliferator-activated receptor gamma (PPARgamma). The addition of exogenous N-acetylsphingosine (C2-ceramide) or increasing endogenous ceramide levels inhibited the expression of C/EBPalpha and PPARgamma, and blocked adipocyte development. C2-ceramide did not decrease the cellular expression of C/EBPbeta, which is required for expression of C/EBPalpha and PPARgamma, but significantly blocked its transcriptional activity from a promoter construct after 24 h. The ceramide-induced decrease in the transcriptional activity of C/EBPbeta correlated with a strong decrease in its phosphorylation, DNA-binding ability and nuclear localization at 24 h. However, ceramide did not change the nuclear level of C/EBPbeta after a period of 4 or 16 h, suggesting that it was not affecting nuclear import. CRM1 (more recently named 'exportin-1') is a nuclear membrane protein that regulates protein export from the nucleus by binding to a specific nuclear export sequence. Leptomycin B is an inhibitor of CRM1/exportin-1, and reversed the ceramide-induced decrease in nuclear C/EBPbeta at 24 h. Taken together, these data support the hypothesis that ceramide may inhibit adipogenesis, at least in part, by enhancing dephosphorylation and premature nuclear export of C/EBPbeta at a time when its maximal transcriptional activity is required to drive adipogenesis.
Asunto(s)
Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Esfingosina/análogos & derivados , Esfingosina/farmacología , Células 3T3 , Transporte Activo de Núcleo Celular/efectos de los fármacos , Adipocitos/citología , Animales , Proteína alfa Potenciadora de Unión a CCAAT/metabolismo , Diferenciación Celular/efectos de los fármacos , Línea Celular , ADN/metabolismo , Humanos , Ratones , Receptores Citoplasmáticos y Nucleares/metabolismo , Esfingosina/metabolismo , Células Madre/citología , Células Madre/efectos de los fármacos , Células Madre/metabolismo , Factores de Transcripción/metabolismo , Activación Transcripcional/efectos de los fármacosRESUMEN
Normal animals contain an autoreactive B lymphocyte subset, the B-1 subset, which is controlled by undefined mechanisms to prevent autoimmunity. Using a V(H)11V(kappa)9 Ig transgenic mouse, with a specificity prototypic of the subset, we have explored conditions responsible for the previously reported Ag hyporesponsiveness of these cells. We report that peritoneal V(H)11V(kappa)9 B cells exhibit typical B-1 behavior with high basal intracellular free Ca(2+) and negligible receptor-mediated calcium mobilization. However, splenic B cells from this mouse, while phenotypically similar to their peritoneal counterparts, including expression of CD5, mount robust B-2-like responses to Ag as measured by calcium influx and altered tyrosine phosphorylation responses. When these splenic cells are adoptively transferred to the peritoneal cavity and encounter their cognate self-Ag, they acquire a B-1 signaling phenotype. The ensuing hyporesponsiveness is characterized by increases in both basal intracellular calcium and resting tyrosyl phosphorylation levels and is highlighted by a marked abrogation of B cell receptor-mediated calcium mobilization. Thus, we show that self-Ag recognition in specific microenvironments such as the peritoneum, and we would propose other privileged sites, confers a unique form of anergy on activated B cells. This may explain how autoreactive B-1 cells can exist while autoimmunity is avoided.
Asunto(s)
Autoinmunidad , Subgrupos de Linfocitos B/inmunología , Receptores de Antígenos de Linfocitos B/metabolismo , Traslado Adoptivo , Animales , Subgrupos de Linfocitos B/metabolismo , Calcio/metabolismo , Señalización del Calcio , Anergia Clonal , Activación de Linfocitos , Ratones , Ratones Transgénicos , Modelos Inmunológicos , Cavidad Peritoneal/citología , Fenotipo , Receptores de Antígenos de Linfocitos B/genética , Bazo/citología , Bazo/inmunologíaRESUMEN
Incomplete urethral tubularization (hypospadias) and anorectal abnormalities are two common and poorly understood birth defects that affect the extreme caudal midline of the human embryo. We now show that cell surface molecules essential for proper axon pathfinding in the developing nervous system, namely ephrin-B2 and the ephrin receptors EphB2 and EphB3, also play major roles in cell adhesion events that tubularize the urethra and partition the urinary and alimentary tracts. Mice carrying mutations which disrupt the bidirectional signals that these molecules transduce develop with variably penetrant severe hypospadias and incomplete midline fusion of the primitive cloaca. We further show that animals completely lacking ephrin-B2 reverse signaling present a fully penetrant failure in cloacal septation. This results in severe anorectal malformations characterized by an absence of the terminal-most hindgut (rectum) and formation of a fistula that aberrantly connects the intestines to the urethra at the base of the bladder. Consistent with an apparent requisite for both forward and reverse signaling in these caudal remodeling events, EphB2 and ephrin-B2 are coexpressed at the midline in the fusing urethral/cloacal endoderm and underlying lateral mesoderm of the urorectal septum that migrates toward the caudal midline as the cloaca septates. Our data thus indicate that B-subclass Eph and ephrin molecules play an important role in these clinically significant midline cell-cell adhesion and fusion events.